Differential Expression of Three Matrix Metalloproteinases, MMP-19, MMP-26, and MMP-28, in Normal and Inflamed Intestine and Colon Cancer

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2004 Jun 10

PMID 15185874

Citations 29

Authors

V O Bister

M T Salmela

M L Karjalainen-Lindsberg

J Uria

J Lohi

P Puolakkainen

C Lopez-Otin

U Saarialho-Kere

Affiliations

Soon will be listed here.

Abstract

Several matrix metalloproteinases (MMPs) have been implicated in intestinal inflammation, mucosal wound healing, and cancer progression. The purpose of this study was to examine the cellular location and putative function of MMP-19, MMP-26 (matrilysin-2), and MMP-28 (epilysin), in normal, inflammatory, and malignant conditions of the intestine. Peroperative tissue specimens from patients with ulcerative colitis (UC) (n = 16) and archival tissue samples of ischemic colitis (n = 9), Crohn's disease (n = 7), UC (n = 8), colon cancer (n = 20), and healthy intestine (n = 5) were examined using immunohistochemical analyses with polyclonal antibodies. Unlike many classical MMPs, MMP-19, MMP-26, and MMP-28 were all expressed in normal intestine. In inflammatory bowel disease (IBD), MMP- 19 was expressed in nonmigrating enterocytes and shedding epithelium. MMP-26 was detected in migrating enterocytes, unlike MMP-28. In colon carcinomas, MMP-19 and MMP-28 expression was downregulated in tumor epithelium. Staining for MMP-26 revealed a meshwork-like pattern between cancer islets, which was absent from most dedifferentiated areas. Our results suggest that MMP-19 is involved in epithelial proliferation and MMP-26 in enterocyte migration, while MMP-28 expression is not associated with inflammatory and destructive changes seen in IBD. In contrast to many previously characterized MMPs, MMP-19 and MMP-28 are downregulated during malignant transformation of the colon and may play a prominent role in tissue homeostasis.

Citing Articles

Development and Validation of a Non-Invasive Prediction Model for Glioma-Associated Epilepsy: A Comparative Analysis of Nomogram and Decision Tree.

Zhong Z, Yu H, Tong Y, Li J Int J Gen Med. 2025; 18:1111-1125.

PMID: 40026809 PMC: 11872099. DOI: 10.2147/IJGM.S512814.

Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.

Sampaio Moura N, Schledwitz A, Alizadeh M, Patil S, Raufman J Front Oncol. 2024; 13:1325095.

PMID: 38288108 PMC: 10824561. DOI: 10.3389/fonc.2023.1325095.

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis.

Bian Y, Xiang Z, Wang Y, Ren Q, Chen G, Xiang B Front Pharmacol. 2023; 14:1285455.

PMID: 38035026 PMC: 10684723. DOI: 10.3389/fphar.2023.1285455.

Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.

Luan H, Jian L, Huang Y, Guo Y, Zhou L Sci Rep. 2023; 13(1):17211.

PMID: 37821678 PMC: 10567842. DOI: 10.1038/s41598-023-44506-8.

Matrix metalloproteinase profiling and their roles in disease.

Chang M RSC Adv. 2023; 13(9):6304-6316.

PMID: 36825288 PMC: 9942564. DOI: 10.1039/d2ra07005g.

References

Zhang J, Cao Y, Zhao Y, Sang Q, Duan E . Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod. 2002; 8(7):659-66. DOI: 10.1093/molehr/8.7.659. View

Schonbeck U, Mach F, Libby P . Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998; 161(7):3340-6. View

Li Q, Wang H, Zhao Y, Lin H, Sang Q, Zhu C . Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy. Mol Hum Reprod. 2002; 8(10):934-40. DOI: 10.1093/molehr/8.10.934. View

Park H, Ni J, Gerkema F, Liu D, Belozerov V, Sang Q . Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000; 275(27):20540-4. DOI: 10.1074/jbc.M002349200. View

Mauch S, Kolb C, Kolb B, Sadowski T, Sedlacek R . Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J Immunol. 2002; 168(3):1244-51. DOI: 10.4049/jimmunol.168.3.1244. View

Haro H, Crawford H, Fingleton B, Shinomiya K, Spengler D, Matrisian L . Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest. 2000; 105(2):143-50. PMC: 377426. DOI: 10.1172/JCI7091. View

Vihinen P, Kahari V . Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002; 99(2):157-66. DOI: 10.1002/ijc.10329. View

Marchenko G, Strongin A . MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene. 2001; 265(1-2):87-93. DOI: 10.1016/s0378-1119(01)00360-2. View

Nagase H, Woessner Jr J . Matrix metalloproteinases. J Biol Chem. 1999; 274(31):21491-4. DOI: 10.1074/jbc.274.31.21491. View

10.

de Coignac A, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry J . Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem. 2000; 267(11):3323-9. DOI: 10.1046/j.1432-1327.2000.01363.x. View

11.

Bresnihan B . Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol. 1999; 26(3):717-9. View

12.

Pender S, Salmela M, Monteleone G, Schnapp D, McKenzie C, Spencer J . Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am J Pathol. 2000; 157(6):1955-62. PMC: 1885781. DOI: 10.1016/s0002-9440(10)64834-1. View

13.

Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M . Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum. 1999; 42(1):129-36. DOI: 10.1002/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4. View

14.

Illman S, Keski-Oja J, Lohi J . Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene. 2001; 275(1):185-94. DOI: 10.1016/s0378-1119(01)00664-3. View

15.

Vaalamo M, Puolakkainen P, Airola K, Parks W, Karjalainen-Lindsberg M . Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol. 1996; 148(2):519-26. PMC: 1861683. View

16.

Westermarck J, Kahari V . Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999; 13(8):781-92. View

17.

Djonov V, Hogger K, Sedlacek R, Laissue J, Draeger A . MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol. 2001; 195(2):147-55. DOI: 10.1002/path.927. View

18.

Stracke J, Fosang A, Last K, Mercuri F, Pendas A, Llano E . Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett. 2000; 478(1-2):52-6. DOI: 10.1016/s0014-5793(00)01819-6. View

19.

Salmela M, MacDonald T, Black D, Irvine B, Zhuma T, Saarialho-Kere U . Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut. 2002; 51(4):540-7. PMC: 1773375. DOI: 10.1136/gut.51.4.540. View

20.

Kolb C, Mauch S, Krawinkel U, Sedlacek R . Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp Cell Res. 1999; 250(1):122-30. DOI: 10.1006/excr.1999.4493. View